Newborn screening for severe combined immunodeficiency in the US: Current status and approach to management

International Journal of Neonatal Screening

Volumn 3, Issue 2, 2017, Pages

  Dorsey, Morna ^a   Puck, Jennifer ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Newborn screening; Preterm; Severe combined immunodeficiency; T lymphopenia; TRECs

Indexed keywords

EID: 85039068283     PISSN: None     EISSN: 2409515X     Source Type: Journal    
DOI: 10.3390/ijns3020015     Document Type: Review

References (20)

1. IDF SCID Newborn Screening Campaign. Available online: http://primaryimmune.org/idf-advocacy-center/idf-scid-newborn-screening-campaign/ (accessed on 26 May 2017).
2. Buckley, R.H. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu. Rev. Immunol. 2004, 22, 625–655. [CrossRef] [PubMed]
3. Ochs, H.D.; Puck, J.M. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach; Oxford University Press: Oxford, UK, 2013; p. 92.
4. Shearer, W.T.; Dunn, E.; Notarangelo, L.D.; Dvorak, C.C.; Puck, J.M.; Logan, B.R.; Griffith, L.M.; Kohn, D.B.; O’Reilly, R.J.; Fleisher, T.A.; et al. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and omenn syndrome: The primary immune deficiency treatment consortium experience. J. Allergy Clin. Immunol. 2014, 133, 1092–1098. [CrossRef] [PubMed]
5. Pai, S.Y.; Logan, B.R.; Griffith, L.M.; Buckley, R.H.; Parrott, R.E.; Dvorak, C.C.; Kapoor, N.; Hanson, I.C.; Filipovich, A.H.; Jyonouchi, S.; et al. Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N. Engl. J. Med. 2014, 371, 434–446. [CrossRef] [PubMed]
6. Chan, K.; Puck, J.M. Development of population-based newborn screening for severe combined immunodeficiency. J. Allergy Clin. Immunol. 2005, 115, 391–398. [CrossRef] [PubMed]
7. Morinishi, Y.; Imai, K.; Nakagawa, N.; Sato, H.; Horiuchi, K.; Ohtsuka, Y.; Kaneda, Y.; Taga, T.; Hisakawa, H.; Miyaji, R.; et al. Identification of severe combined immunodeficiency by t-cell receptor excision circles quantification using neonatal guthrie cards. J. Pediatr. 2009, 155, 829–833. [CrossRef] [PubMed]
8. Hitzig, W.H.; Biro, Z.; Bosch, H.; Huser, H.J. Agammaglobulinemia & alymphocytosis with atrophy of lymphatic tissue. Helv. Paediatr. Acta 1958, 13, 551–585. [PubMed]
9. Giblett, E.; Anderson, J.; Cohen, F.; Pollara, B.; Meuwissen, H.J. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 1972, 300, 1067–1069. [CrossRef]
10. Gatti, R.; Meuwissen, H.; Allen, H.; Hong, R.; Good, R.A. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968, 292, 1366–1369. [CrossRef]
11. Noguchi, M.; Yi, H.; Rosenblatt, H.M.; Filipovich, A.H.; Adelstein, S.; Modi, W.S.; McBride, O.W.; Leonard, W.J. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993, 73, 147–157. [CrossRef]
12. Puck, J.M.; Deschenes, S.M.; Porter, J.C.; Dutra, A.S.; Brown, C.J.; Willard, H.F.; Henthorn, P.S. The interleukin-2 receptor γ chain maps to Xq13. 1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum. Mol. Genet. 1993, 2, 1099–1104. [CrossRef] [PubMed]
13. Picard, C.; Al-Herz, W.; Bousfiha, A.; Casanova, J.L.; Chatila, T.; Conley, M.E.; Rundles, C.C.; Etzioni, A.; Holland, S.M.; Klein, C.; et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. J. Clin. Immunol. 2015, 35, 696–726. [CrossRef] [PubMed]
14. Kwan, A.; Abraham, R.S.; Currier, R.; Brower, A.; Andruszewski, K.; Abbott, J.K.; Baker, M.; Ballow, M.; Bartoshesky, L.E.; Bonagura, V.R.; et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. Netw. 2014, 312, 729–738. [CrossRef] [PubMed]
15. Dorsey, M.J.; Dvorak, C.C.; Cowan, M.J.; Puck, J.M. Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening. J. Allergy Clin. Immunol. 2017, 139, 733–742. [CrossRef] [PubMed]
16. Heimall, J.; Logan, B.R.; Cowan, M.J.; Notarangelo, L.D.; Puck, J.; Fleisher, T.; Griffith, L.M.; Kohn, D.B.; Pulsipher, M.A.; Shearer, W.; et al. Poor T cell reconstitution at 100 days after T cell-replete hematopoietic cell transplantation (HCT) for SCID is associated with later risk of death or need for 2nd transplant in the 6901 prospective study of the pidtc. Biol. Blood Marrow Transpl. 2016, 22, S101–S102. [CrossRef]
17. Volpi, S.; Yamazaki, Y.; Brauer, P.M.; Rooijen, E.V.; Hayashida, A.; Slavotinek, A.; Kuehn, H.S.; Rocco, M.D.; Rivolta, C.; Bortolomai, I.; et al. EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay. J. Exp. Med. 2017. [CrossRef] [PubMed]
18. Hannon, W.H.; Abraham, R.S.; Kobrynski, L.; Vogt, L.; Adair, O.; Aznar, C.; Baker, M.W.; Brower, A.M.; Caggana, M.; Comeau, A.M.; et al. Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline. Clin. Lab. Inst. Stand. 2013, 33, 1–75.
19. Kwan, A.; Church, J.A.; Cowan, M.J.; Agarwal, R.; Kapoor, N.; Kohn, D.B.; Lewis, D.B.; McGhee, S.A.; Moore, T.B.; Stiehm, E.R.; et al. Newborn screening for severe combined immunodeficiency and t-cell lymphopenia in California: results of the first 2 years. J. Allergy Clin. Immunol. 2013, 132, 140–150. [CrossRef] [PubMed]
20. Grunebaum, E.; Cutz, E.; Roifman, C.M. Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency. J. Allergy Clin. Immunol. 2012, 129, 1588–1593. [CrossRef] [PubMed]